Trade OCGN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Ocugen, Inc. (OCGN) is trading at US$0.80, down 1.19% today as of Oct 16, 13:33 EDT. The company has a market capitalisation of US$471.36M. Over the past 52 weeks, OCGN has traded between US$0.79 and US$2.73. On Syfe you can trade OCGN with $0 commission and add it to your watchlist.
| Previous close | US$0.81 |
|---|---|
| Market cap | US$471.36M |
| 52-week range | US$0.79 – US$2.73 |
| Volume | 5.85M |
| Exchange | US |
Ocugen, Inc.
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Year: 2014
Ocugen Insider Sold Shares Worth $589,110, According to a Recent SEC Filing
Sep 14, 8:32 AM · MT Newswires
Ocugen Doses First Patient in Trial of Potential Eye Disease Drug
Sep 1, 11:35 AM · MT Newswires
Ocugen, Inc. (OCGN) stock is trading at US$0.80, -1.19% from the previous close of US$0.81.
The market cap for Ocugen, Inc. (OCGN) stock is approximately US$471.36M.
The 52-week high for Ocugen, Inc. (OCGN) stock is US$2.73.
The 52-week low for Ocugen, Inc. (OCGN) stock is US$0.79.
Ocugen, Inc. (OCGN) does not currently pay a dividend.
Stay on top of OCGN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
